There were 525 press releases posted in the last 24 hours and 170,478 in the last 365 days.

Pregistry Receives Award from Global Health & Pharma

Recognized as "Best Pregnancy & Lactation Information Platform" in the 2019 Healthcare & Pharmaceutical Awards category

About 75 percent of all pregnant women take at least one prescription medication during pregnancy. However, less than 10 percent have been properly evaluated. This is of great concern to all of us.”
— Dr. Diego Wyszynski

LOS ANGELES, CALIFORNIA, UNITED STATES, February 6, 2020 /EINPresswire.com/ -- Pregistry, LLC, an emerging leader in the development and execution of post-approval studies to assess the safety of medications and vaccines used during pregnancy and lactation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.

Pregistry was recognized as the "Best Pregnancy & Lactation Information Platform" in the 2019 Healthcare & Pharmaceutical Awards category of Global Health & Pharma. The Healthcare & Pharmaceutical Awards recognize visionary companies and individuals for harnessing disruptive ideas which will drive the healthcare and pharmaceutical industries forward. Pregistry has developed one of the world’s largest communities of pregnant and breastfeeding women with the goal to conduct observational research on the safety of medicines and vaccines used during pregnancy. Over 600,000 pregnant and nursing women are in Pregistry’s ever-growing pool, drawn in by the useful and practical information and tools that are offered online and without charge. Ultimately, this means that Pregistry is in the perfect position to send out surveys, analyze the responses, and communicate the findings on behalf of pharmaceutical companies, academia, and regulators.

Pregistry has an interesting business model. It exists simultaneously for the benefit of the pharmaceutical industry and, more specifically, for companies that have products that will likely be used by women of childbearing potential, and for pregnant women who receive useful information and tools. “Usually, we get involved during the drug’s phase III activities,” says Dr. Diego Wyszynski, CEO of Pregistry, “although it is not uncommon for us to be asked to consult during phase II of development. Predictably, most large studies we conduct, such as pregnancy exposure registries and analyses of administrative databases, occur when the drug is already on the market.”

"Our mission is to fill a major gap in information about the risks of medicines and vaccines during pregnancy and lactation to help women and their health care providers make informed, evidence-based health care decisions that optimize maternal and infant outcomes," said Dr. Wyszynski. "For the last six years, we have worked extensively to develop and offer a large amount of information and tools free of charge, including expert reports on thousands of medications, exposures, and medical conditions. These expert reports can be saved and shared easily. Also, on pregistry.com our maternal health experts are available to answer questions 24/7. And, to facilitate communication among pregnant women, we have fantastic social forums that attract thousands of people every week."

An interview with Dr. Wyszynski can be found here: https://www.ghp-news.com/issues/q4-2019/13/

To learn more about Pregistry, its communities, or services to the pharmaceutical industry, please visit https://www.pregistry.com.

About Pregistry, LLC
Pregistry is an emerging global leader in the development and execution of observational studies to assess the safety of medications and vaccines when used during pregnancy and lactation. With over 40 pregnancy specialists, covering a range of clinical, preclinical, safety, regulatory, marketing, and IT needs, the focus is on making sure that both mother and baby are healthy and safe and that prescribers have the information needed to be able to explain the potential benefits and risks of medications during pregnancy and lactation. To learn more, please visit: https://www.pregistry.com.

About Global Health & Pharma
GHP is a global information sharing platform & multi-disciplinary members community established to enhance communication & collaboration across Human, Animal and Environmental Health. Global Health & Pharma Magazine is the go-to resource on developing issues in healthcare and pharmaceuticals for over 260,000 wellness professionals and healthcare-related suppliers across four continents. Our informed readership includes individuals at all levels of their respective industries, from CEOs to healthcare professionals, nurses and support service workers. To learn more, please visit https://www.ghp-news.com.

About Global Health & Pharma Awards
When it comes to handing out recognition and awards, we believe there are few more deserving than those whose dedication changes the lives of millions of people every day. Our awards recognize innovation and courage in all aspects of the healthcare and pharmaceutical industries, including practitioners, scientists, nurses, architects, product designers, legal specialists and corporate decision makers. We believe all these roles are responsible for the life-changing innovations we see daily.

Media Contact:
AK Parks
hello@pregistry.com

AK Parks
Pregistry
email us here
+1 323-744-6613
Visit us on social media:
Facebook
Twitter
LinkedIn

Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.